SMAD3 and pulmonary fibrosis: Our results showed that PTX treatment not only suppressed TGF-β1-activated Smad3/p-Smad3 at mRNA or protein levels to further reverse subsequent EMT in A549 cells, but also downregulated p-Smad3 levels to improve subsequent pulmonary fibrosis in rat lungs.